Adding Intranasal to Oral Administration of an Ultra-Rapid Near-Universal Drug Regimen Accelerates Relapse-Free Cure of Tuberculosis in Mice
Open Access
- 11 June 2025
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 232 (3) , e442-e447
Abstract
We previously identified a potent 4-drug oral regimen comprising clofazimine, bedaquiline, pyrazinamide, and delamanid (parabolic response surface [PRS] regimen V) that dramatically shortens by approximately 85% the treatment duration needed to attain relapse-free cure of tuberculosis in mice compared with the standard regimen. Here, we investigated if intranasal administration of the PRS regimen V antibiotics bedaquiline and delamanid on top of the oral regimen would further accelerate tuberculosis cure in mice. We show that adding the intranasal to oral regimen further lowers lung burden of tubercle bacilli and significantly more rapidly achieves relapse-free cure. Hence, adding inhalational to oral therapy can potentially accelerate cure of tuberculosis.Keywords
Funding Information
- Department of Defense CDMRP (PR190949)
This publication has 14 references indexed in Scilit:
- Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2025
- The efficacy and safety of inhaled antibiotics for pneumonia: A systematic review and meta-analysisPulmonary Pharmacology & Therapeutics, 2024
- Partial liquid ventilation for bronchopulmonary dysplasia: Visualizing ventilation patterns on chest radiographsPediatrics & Neonatology, 2019
- Ultra-rapid near universal TB drug regimen identified via parabolic response surface platform cures mice of both conventional and high susceptibilityPLOS ONE, 2018
- Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment timeNature Communications, 2017
- Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture modelProceedings of the National Academy of Sciences, 2016
- Immediate Changes in Lung Compliance Following Natural Surfactant Administration in Premature Infants with Respiratory Distress Syndrome: a Controlled TrialJournal of Perinatology, 2004
- Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesiaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2002
- Partial Liquid Ventilation with Perflubron in Premature Infants with Severe Respiratory Distress SyndromeNew England Journal of Medicine, 1996
- Techniques for drug delivery to the airways, and the assessment of lung function in animal modelsJournal of Pharmacological and Toxicological Methods, 1992